Category Archives: Basil Petrof

View his faculty profile here: Basil Petrof, MD
Professor, Department of Medicine, McGill University
Director, Meakins-Christie Laboratories
Research Theme: Study of injury/regeneration, adaptation, & development of gene therapeutics for respiratory muscles
Keywords: diaphragm • muscular dystrophy • ICU-acquired muscle weakness • sepsis • neuromuscular respiratory failure
View Basil Petrof’s recent posts and news below.

Pulmonary research in Canada: the Meakins-Christie Laboratories

Dr. Basil Petrof appointed Director of the Meakins-Christie Laboratories

Dr. Basil Petrof, Professor of Medicine, has been appointed Director of the Meakins-Christie Laboratories effective May 15, 2017, for a five-year term. As Director, Dr. Petrof will be responsible for the scientific leadership and administration of the Meakins-Christie Laboratories. Dr. Petrof is an accomplished and internationally recognized scientist for his work on respiratory muscle dysfunction and sleep-disordered breathing.

Respiratory research group in Canada: the Meakins-Christie Laboratories

Accelerating new treatments for respiratory diseases

Watch Dr. Basil Petrof’s podcast below. The CFI talks to our researchers about Innovation at the Glen and new respiratory disease treatments.

Basil Petrof heads the program for translational research in respiratory diseases at the Research Institute of the McGill University Health Centre (RI-MUHC). His research group recently participated in a clinical trial that proved the efficacy of a new therapy that burns away the muscle tissue in the lungs of asthmatic patients to help open their airways. It is this kind of cutting-edge discovery that Petrof expects will move more rapidly from concept to proven treatment thanks to the new facilities at the RI-MUHC. (February 2015)

Basil Petrof: Accelerating new treatments for respiratory diseases  – Podcast